SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,680.00    30.00 (0.53%)
Bid:
5,670.00
Ask:
5,680.00
Spread: 10.00 (0.176%)
Market Cap: £3.04b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Trading Statement

2 Feb 2017 07:00

RNS Number : 7979V
Cranswick PLC
02 February 2017
 

2 February 2017

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

 

Third quarter trading statement

 

Cranswick, a leading UK food producer, today provides an update on trading for the three months to 31 December 2016.

 

Current trading

Trading during the third quarter of the financial year was in line with the Board's expectations.

 

Total and underlying revenue was well ahead of the prior year, underpinned by strong volume growth and supported, as anticipated, by a robust performance over the key Christmas trading period. Export sales continued to grow strongly, with Far East revenues well ahead of the same quarter last year, reflecting both ongoing demand from the region and increased output from the Group's two primary processing facilities.

 

Input costs rose further during the period, but efficiency improvements, internal pig production and constructive pricing discussions with customers helped partially mitigate the impact.

 

Investment

As previously reported, the Group acquired Dunbia Ballymena, a leading Northern Irish pork processing business on 16 November 2016. The business has performed in line with the Board's expectations since acquisition and integration is proceeding to plan.

 

Crown Chicken, which was acquired on 8 April 2016, continued to contribute strongly during the period. The business is being integrated successfully and is forging strong links with the Group's premium cooked poultry and pig farming operations.

 

The Group continues to invest heavily across its asset base to increase capacity, add new capability and drive further operating efficiencies. Work has recently started on the new, purpose-built continental products factory in Bury, Greater Manchester. This substantial investment will consolidate the Group's two existing facilities and provide additional capacity to support this high growth category.

 

Financial position

During the period, the Group refinanced its banking facility on improved terms. The new agreement, which runs to November 2021 with the potential to extend for a further 2 years, comprises a revolving credit facility of £160 million, including a committed overdraft of £20 million. This unsecured facility supports the Group's sound financial position and provides significant headroom for future growth.

 

Net debt increased during the quarter and was above the level reported at the same stage last year, reflecting the anticipated seasonal increase in working capital, the acquisition of Dunbia Ballymena and ongoing capital expenditure.

 

Outlook

With experienced management at all levels of the Group, a strong range of products, a well-invested asset base and a robust financial position, the Board is confident in both the prospects for the remainder of the current financial year and the continued long term success and development of the business.

 

Preliminary results

The Company's next scheduled comment on trading will be the preliminary results announcement on 23 May 2017.

 

Enquiries:

 

Cranswick plc

01482 372 000

Mark Bottomley, Finance Director

Powerscourt

020 7250 1446

Nick Dibden / Lisa Kavanagh / Samantha Trillwood

cranswick@powerscourt-group.com

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, premium fresh and cooked poultry, charcuterie and pastry products. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2016 showed revenue from continuing operations of £1,016m and profit before tax on the same basis of £62.1m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTTBMRTMBMMBAR
Date   Source Headline
24th Nov 20254:59 pmRNSDirector/PDMR Shareholding
3rd Nov 20255:44 pmRNSHolding(s) in Company
3rd Nov 202510:40 amRNSTotal Voting Rights
22nd Oct 20252:06 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSBlock listing six monthly return
2nd Oct 20257:00 amRNSBlock listing six monthly return
2nd Oct 20257:00 amRNSTotal Voting Rights
23rd Sep 20254:31 pmRNSDirector/PDMR Shareholding
17th Sep 20254:43 pmRNSHolding(s) in Company
15th Sep 20258:35 amRNSDirector/PDMR Shareholding
15th Sep 20258:33 amRNSDirector/PDMR Shareholding
11th Sep 202511:30 amRNSTotal Voting Rights
5th Sep 20254:03 pmRNSHolding(s) in Company
4th Sep 20257:56 amRNSHolding(s) in Company
2nd Sep 20255:00 pmRNSHolding(s) in Company
29th Aug 20257:00 amRNSHolding(s) in Company
26th Aug 20259:23 amRNSDirector/PDMR Shareholding
26th Aug 20257:07 amRNSHolding(s) in Company
4th Aug 20259:55 amRNSTotal Voting Rights
28th Jul 20252:51 pmRNSPoll Result for 2025 Annual General Meeting
28th Jul 20257:00 amRNSFirst quarter trading statement
24th Jul 20252:46 pmRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSDirector/PDMR Shareholding
22nd Jul 20251:45 pmRNSHolding(s) in Company
9th Jul 20252:58 pmRNSDirector/PDMR Shareholding
8th Jul 20253:23 pmRNSTotal Voting Rights
8th Jul 20253:17 pmRNSDirector/PDMR Shareholding
30th Jun 202510:00 amRNSDirector/PDMR Shareholding
30th Jun 20259:57 amRNSDirector/PDMR Shareholding
27th Jun 20257:00 amRNSAnnual Report and Accounts and Notice of AGM
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSDirector/PDMR Shareholding
3rd Jun 20253:15 pmRNSDirector/PDMR Shareholding
2nd Jun 20254:48 pmRNSTotal Voting Rights
27th May 20257:00 amRNSHolding(s) in Company
22nd May 20256:25 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSPreliminary Results
13th May 20252:59 pmRNSHolding(s) in Company
6th May 20254:20 pmRNSHolding(s) in Company
25th Apr 202510:11 amRNSDirector/PDMR Shareholding
23rd Apr 20257:00 amRNSDirector/PDMR Shareholding
2nd Apr 20259:02 amRNSBlock listing six monthly return
2nd Apr 20259:02 amRNSBlock listing six monthly return
2nd Apr 20258:58 amRNSTotal Voting Rights
26th Mar 20254:08 pmRNSHolding(s) in Company
26th Mar 20252:22 pmRNSDirector/PDMR Shareholding
25th Mar 20254:12 pmRNSDirector/PDMR Shareholding
24th Mar 20253:39 pmRNSDirector/PDMR Shareholding
20th Mar 20257:00 amRNSCMD and upgraded medium term targets

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.